Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture.

Chertov O, Zhang N, Chen X, Oppenheim JJ, Lubkowski J, McGrath C, Sowder RC 2nd, Crise BJ, Malyguine A, Kutzler MA, Steele AD, Henderson EE, Rogers TJ.

PLoS One. 2011 Jan 11;6(1):e14474. doi: 10.1371/journal.pone.0014474.

2.

Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.

Day CP, Carter J, Bonomi C, Esposito D, Crise B, Ortiz-Conde B, Hollingshead M, Merlino G.

Pigment Cell Melanoma Res. 2009 Jun;22(3):283-95. doi: 10.1111/j.1755-148X.2009.00545.x. Epub 2009 Jan 19.

3.

HIV-1 inactivation by 4-vinylpyridine is enhanced by dissociating Zn(2+) from nucleocapsid protein.

Morcock DR, Thomas JA, Sowder RC 2nd, Henderson LE, Crise BJ, Gorelick RJ.

Virology. 2008 May 25;375(1):148-58. doi: 10.1016/j.virol.2008.01.045. Epub 2008 Mar 4.

4.

Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.

Derse D, Crise B, Li Y, Princler G, Lum N, Stewart C, McGrath CF, Hughes SH, Munroe DJ, Wu X.

J Virol. 2007 Jun;81(12):6731-41. Epub 2007 Apr 4.

5.

Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1.

Crise B, Li Y, Yuan C, Morcock DR, Whitby D, Munroe DJ, Arthur LO, Wu X.

J Virol. 2005 Oct;79(19):12199-204.

6.

Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.

Yang QE, Stephen AG, Adelsberger JW, Roberts PE, Zhu W, Currens MJ, Feng Y, Crise BJ, Gorelick RJ, Rein AR, Fisher RJ, Shoemaker RH, Sei S.

J Virol. 2005 May;79(10):6122-33.

7.
8.

Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.

Morcock DR, Thomas JA, Gagliardi TD, Gorelick RJ, Roser JD, Chertova EN, Bess JW Jr, Ott DE, Sattentau QJ, Frank I, Pope M, Lifson JD, Henderson LE, Crise BJ.

J Virol. 2005 Feb;79(3):1533-42.

9.

Transcription start regions in the human genome are favored targets for MLV integration.

Wu X, Li Y, Crise B, Burgess SM.

Science. 2003 Jun 13;300(5626):1749-51.

10.

Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins.

Chertova E, Crise BJ, Morcock DR, Bess JW Jr, Henderson LE, Lifson JD.

Curr Mol Med. 2003 May;3(3):265-72. Review.

PMID:
12699362
11.

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.

Chertova E, Bess JW Jr, Crise BJ, Sowder II RC, Schaden TM, Hilburn JM, Hoxie JA, Benveniste RE, Lifson JD, Henderson LE, Arthur LO.

J Virol. 2002 Jun;76(11):5315-25.

12.

Combined effects of Venezuelan equine encephalitis IIIA virus and gamma irradiation in mice.

Shoemaker MO, Tammariello R, Crise B, Bouhaouala SS, Knudson GB, Jackson WE 3rd, Ludwig GV, Smith JF.

Mil Med. 2001 Dec;166(12 Suppl):88-9.

PMID:
11778450
13.
14.

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.

Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret JH, Hall RA, MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, Malkinson M, Banet C, Weissman J, Komar N, Savage HM, Stone W, McNamara T, Gubler DJ.

Science. 1999 Dec 17;286(5448):2333-7.

15.
17.
19.

The lateral mobility of some membrane proteins is determined by their ectodomains.

Zhang F, Crise B, Su B, Hou Y, Rose JK, Bothwell A, Jacobson K.

Biophys J. 1992 Apr;62(1):92-4. No abstract available.

20.
21.

Delayed start-up of kinesin-driven microtubule gliding following inhibition by adenosine 5'-[beta,gamma-imido]triphosphate.

Schnapp BJ, Crise B, Sheetz MP, Reese TS, Khan S.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):10053-7.

22.
23.

A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.

Whitt MA, Zagouras P, Crise B, Rose JK.

J Virol. 1990 Oct;64(10):4907-13.

24.

Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein.

Crise B, Ruusala A, Zagouras P, Shaw A, Rose JK.

J Virol. 1989 Dec;63(12):5328-33.

25.

Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells.

Brown DA, Crise B, Rose JK.

Science. 1989 Sep 29;245(4925):1499-501.

PMID:
2571189

Supplemental Content

Support Center